These opportunities to get in at absurd levels do not come along every day. In fact would not be surprised if in last then two quarters they are challenge $40 level again. I've bought and will continue to buy, thank you for the gift that I suspect will keep on giving for the next few years.
Sentiment: Strong Buy
ENDO trades at such a discount to the industry it borders on the absurd. Judges favorable ruling can only mean more $$$ in their pocket and with last acquisition now are the fourth largest generic drug maker. Read Motley Fool article it details their cash position just how undervalued they are, this is a great buying opportunity and when this is trading north of $35 in what will be a blink of the eye, a lot of investors are going to be kicking themselves for not opening a position to add to later, imo.
This could make a short term low in the $10 range tomorrow, be careful, still think this is a triple or more by year end but guidance after market today could be ugly.
Missed on revenue's badly, this is overbought and will see a harsh selloff in the last hour.
Go Check earnings the consensus was expecting -.11 came in at .01 earnings is in about ten days and another earnings beat down is in the cards, look at all the favorable reviews, Gulfport is consistently the stock of choice for everyone...
Gulfport technical look excellent, next leg up 34 than $40... heading back to 52wk high.
See this over $50 shortly.
Run up in NUGT signals capitulation, when you look at expected earnings and how goldl companies are revising down, RGLD will not only miss but this last gasp run up is going to end with a sharp decline.
Could be the beginning of an Ugly Pullback.
Spot on and as someone who has worked as an RN for a decade and knows a thing or two about oncology medication, it's a shame people are falling victim to shorters misuse of the FDAs comments
Cramer doesn't have a clue, if he isn't out of his short position he will be today, these side effects are manageable and certainly not uncommon for oncology medication.
make a boat load of money but so will the longs.
The Irony is some of these basher's are hedging with in the end they think the stock will be approved.
I Would love to have a tenth of one percent of the sales of Warfarin, CLVS drug will be approved and this will go to at least thirty, not to mention a second drug approval on the horizon this year and another one early next year. This is a no brainer